Search for: "Alcon Laboratories, Inc." Results 21 - 40 of 59
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Dec 2017, 9:10 am by Phyllis H. Marcus and Andrew W. Eklund
Alcon Sheds Tears (and Certain Ad Claims) after Challenge by Bausch & Lomb After a challenge by rival contact lens solution manufacturer Bausch & Lomb, the NAD has recommended that Alcon Laboratories, Inc., discontinue claims about its Clear Care and Clear Care Plus contact lens solutions. [read post]
20 Dec 2017, 9:10 am by Phyllis H. Marcus
Alcon Sheds Tears (and Certain Ad Claims) after Challenge by Bausch & Lomb After a challenge by rival contact lens solution manufacturer Bausch & Lomb, the NAD has recommended that Alcon Laboratories, Inc., discontinue claims about its Clear Care and Clear Care Plus contact lens solutions. [read post]
24 Jul 2019, 10:03 am by Dennis Crouch
Reddy’s Laboratories Inc., Docket No. 17-02473 (Fed. [read post]
9 Nov 2006, 1:29 am
An Advocate General's Opinion from the European Court of Justice on which the IPKat has so far failed to comment was given on 26 October in Case C-412/05 P Alcon Inc v OHIM, Biofarma SA.In 1998 Alcon Inc applied to register the word TRAVATAN as a Community trade mark for phthalmic pharmaceutical preparations. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel) –… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
9 Dec 2009, 3:59 pm
Watson Laboratories Inc. - Florida et al  (Patent Docs) Surfaxin (Lucinactant) – US: PTO rules on the availability of multiple interim patent extensions (FDA Law Blog) Taxotere (Docetaxel) – Canada: Federal Court refuses to grant Order of Prohibition against Hospira regarding Docetaxel product: Sanofi v Hospira (Pharmacapsules @ Gowlings) Vigamox (Moxifloxacin) – US: Teva appeals verdict finding ANDA to market generic Vigamox infringes patent: Alcon… [read post]